Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Novo Nordisk appoints Curtis Oltmans to US executive team

January 8, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans

Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …
Appointment

Marketing excellence: how to win over your internal audience

January 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Manastersky, marketing

You’ve spent months building a marketing excellence training curriculum which has been prioritised by marketing leadership as a critically important …
Feature
david_cook

David Cook appointed chief financial officer of Biotie

January 7, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Biotie, David Cook

David Cook has been appointed chief financial officer (CFO) of drug development firm Biotie Therapies and will become a member …
Appointment

Pressure on pharma M&A

January 7, 2013 Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers

The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …
News
sarah_bater

Celgene appoints new Human Resources director

January 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …
Appointment

Contract research news in brief

December 21, 2012 Research and Development Almac, Clinipace, Harrison Clinical Research, PRA, Quintiles, Synteract, WuXi PharmaTech

Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and a new accreditation for Quintiles’ …
News

Merck KGaA pipeline hit

December 21, 2012 Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …
News

Sanofi global operations president to retire

December 20, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …
Appointment

Sanofi – aiming for number one in the world’s biggest diabetes market

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Sanofi, diabetes, obesity

Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …
Feature
haslam

David Haslam confirmed as NICE chair

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Haslam, Hunt, NICE

David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …
Appointment
eckert

Amgen appoints Mattel’s Robert Eckert to Board of directors

December 14, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert

Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …
Appointment
Astrazeneca image

RA setbacks for AstraZeneca and Lilly

December 14, 2012 Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly

AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …
News
stack

David Stack appointed to Amarin Board of directors

December 14, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack

Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of …
Appointment

Hold tight: a bumpy ride ahead for the NHS

December 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, NHS, Wallards, reforms

The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …
Feature
barbara_domayne-hayman

Stevenage Bioscience Catalyst hires first entrepreneur-in-residence

December 13, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Stevenage Bioscience Catalyst

Early-stage biotech firm Stevenage Bioscience Catalyst (SBC) has appointed Dr Barbara Domayne-Hayman as its first entrepreneur-in-residence. Domayne-Hayman will work with …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025